Citation: | XIE Shuo, LI Jia-xin, LIU Xin-min, JIAO Hong-mei. Characteristics and predictive factors of chronic critical illness[J]. Chinese Journal of General Practice, 2022, 20(9): 1555-1559. doi: 10.16766/j.cnki.issn.1674-4152.002648 |
[1] |
ROSENTHAL M D, KAMEL A Y, ROSENTHAL C M, et al. Chronic critical illness: Application of what we know[J]. Nutr Clin Pract, 2018, 33(1): 39-45. doi: 10.1002/ncp.10024
|
[2] |
HESSELINK L, HOEPELMAN R J, SPIJKERMAN R, et al. Persistent inflammation, immunosuppression and catabolism syndrome (PICS) after polytrauma: A rare syndrome with major consequences[J]. J Clin Med, 2020, 9(1): 191. doi: 10.3390/jcm9010191
|
[3] |
LOFTUS T J, MIRA J C, OZRAZGAT-BASLANTI T, et al. Sepsis and Critical Illness Research Center investigators: Protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients[J]. BMJ Open, 2017, 7(7): e015136. DOI: 10.1136/bmjopen-2016-015136.
|
[4] |
STORTZ J A, MURPHY T J, RAYMOND S L, et al. Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis[J]. Shock, 2018, 49(3): 249-258. doi: 10.1097/SHK.0000000000000981
|
[5] |
MANKOWSKI R T, ANTON S D, GHITA G L, et al. Older adults demonstrate biomarker evidence of the persistent inflammation, immunosuppression, and catabolism syndrome (PICS) after sepsis[J]. J Gerontol A Biol Sci Med Sci, 2022, 77(1): 188-196. doi: 10.1093/gerona/glab080
|
[6] |
LOSS S H, NUNES D S L, FRANZOSI O S, et al. Chronic critical illness: Are we saving patients or creating victims?[J]. Rev Bras Ter Intensiva, 2017, 29(1): 87-95.
|
[7] |
GARDNER A K, GHITA G L, WANG Z, et al. The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs[J]. Crit Care Med, 2019, 47(4): 566-573. doi: 10.1097/CCM.0000000000003655
|
[8] |
KAHN J M, LE T, ANGUS D C, et al. The epidemiology of chronic critical illness in the United States[J]. Crit Care Med, 2015, 43(2): 282-287. doi: 10.1097/CCM.0000000000000710
|
[9] |
OHBE H, MATSUI H, FUSHIMI K, et al. Epidemiology of chronic critical illness in Japan: A nationwide inpatient database study[J]. Crit Care Med, 2021, 49(1): 70-78.
|
[10] |
李思澄, 吴婕, 于湘友, 等. 中国慢性危重症及外科相关慢性危重症的多中心横断面研究[J]. 中华胃肠外科杂志, 2019, 22(11): 1027-1033.
LI S C, WU J, YU X Y, et al. A multicenter cross sectional study on chronic critical illness and surgery related chronic critical illness in China[J]. Chinese Journal of Gastrointestinal Surgery, 2019, 22(11): 1027-1033.
|
[11] |
DENNING N L, AZIZ M, GURIEN S D, et al. DAMPs and NETs in sepsis[J]. Front Immunol, 2019, 10: 2536. doi: 10.3389/fimmu.2019.02536
|
[12] |
HU Q Y, REN J A, WU J, et al. Elevated levels of plasma mitochondrial DNA are associated with clinical outcome in intra-abdominal infections caused by severe trauma[J]. Surg Infect (Larchmt), 2017, 18(5): 610-618. doi: 10.1089/sur.2016.276
|
[13] |
RAYMOND S L, HOLDEN D C, MIRA J C, et al. Microbial recognition and danger signals in sepsis and trauma[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(10 Pt B): 2564-2573.
|
[14] |
NOMELLINI V, KAPLAN L J, SIMS C A, et al. Chronic critical illness and persistent inflammation: What can we learn from the elderly, injured, septic, and malnourished?[J]. Shock, 2018, 49(1): 4-14. doi: 10.1097/SHK.0000000000000939
|
[15] |
FENNER B P, DARDEN D B, KELLY L S, et al. Immunological endotyping of chronic critical illness after severe sepsis[J]. Front Med (Lausanne), 2021, 7: 616694. DOI: 10.3389/fmed.2020.616694.
|
[16] |
STORTZ J A, MIRA J C, RAYMOND S L, et al. Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients[J]. J Trauma Acute Care Surg, 2018, 84(2): 342-349. doi: 10.1097/TA.0000000000001758
|
[17] |
RHODES A, EVANS L E, ALHAZZANI W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377. doi: 10.1007/s00134-017-4683-6
|
[18] |
李勇, 郭敏, 康英英. MicroRNA在甲状腺癌中的研究进展[J]. 中华全科医学, 2022, 20(2): 298-301, 351. doi: 10.16766/j.cnki.issn.1674-4152.002337
LI Y, GUO M, KANG Y Y. Research progress of microRNA in thyroid cancer[J]. Chinese Journal of General Practice, 2022, 20(2): 298-301, 351. doi: 10.16766/j.cnki.issn.1674-4152.002337
|
[19] |
REITHMAIR M, BUSCHMANN D, MÄRTE M, et al. Cellular and extracellular miRNAs are blood-compartment-specific diagnostic targets in sepsis[J]. J Cell Mol Med, 2017, 21(10): 2403-2411. doi: 10.1111/jcmm.13162
|
[20] |
VEGLIA F, SANSEVIERO E, GABRILOVICH D I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity[J]. Nat Rev Immunol, 2021, 21(8): 485-498. doi: 10.1038/s41577-020-00490-y
|
[21] |
HEINE A, HELD S A E, SCHULTE-SCHREPPING J, et al. Generation and functional characterization of MDSC-like cells[J]. Oncoimmunology, 2017, 6(4): e1295203. DOI: 10.1080/2162402X.2017.1295203.
|
[22] |
SHAH A, CHESTER-JONES M, DUTTON S J, et al. Intravenous iron to treat anaemia following critical care: A multicentre feasibility randomised trial[J]. Br J Anaesth, 2022, 128(2): 272-282. doi: 10.1016/j.bja.2021.11.010
|
[23] |
ROSENTHAL M D, BALA T, WANG Z, et al. Chronic critical illness patients fail to respond to current evidence-based intensive care nutrition secondarily to persistent inflammation, immunosuppression, and catabolic syndrome[J]. JPEN J Parenter Enteral Nutr, 2020, 44(7): 1237-1249. doi: 10.1002/jpen.1794
|
[24] |
BASTUG A, BODUR H, ERDOGAN S, et al. Clinical and laboratory features of COVID-19: Predictors of severe prognosis[J]. Int Immunopharmacol, 2020, 88: 106950. DOI: 10.1016/j.intimp.2020.106950.
|
[25] |
HU C, CHEN K N, TANG X P. Prognostic value of preoperative controlling nutritional status in patients with glioblastoma[J]. Clin Neurol Neurosurg, 2020, 198: 106129. DOI: 10.1016/j.clineuro.2020.106129.
|
[26] |
ROSENTHAL M D, VANZANT E L, MOORE F A. Chronic critical illness and PICS nutritional strategies[J]. J Clin Med, 2021, 10(11): 2294. doi: 10.3390/jcm10112294
|
[27] |
PICCA A, LEZZA A M S, LEEUWENBURGH C, et al. Circulating mitochondrial DNA at the crossroads of mitochondrial dysfunction and inflammation during aging and muscle wasting disorders[J]. Rejuvenation Res, 2018, 21(4): 350-359. doi: 10.1089/rej.2017.1989
|
[28] |
MIRA J C, BRAKENRIDGE S C, MOLDAWER L L, et al. Persistent inflammation, immunosuppression and catabolism syndrome[J]. Crit Care Clin, 2017, 33(2): 245-258. doi: 10.1016/j.ccc.2016.12.001
|
[29] |
PAGE A, FLOWER L, PROWLE J, et al. Novel methods to identify and measure catabolism[J]. Curr Opin Crit Care, 2021, 27(4): 361-366. doi: 10.1097/MCC.0000000000000842
|
[30] |
FERRIE S, TSANG E. Monitoring nutrition in critical illness: What can we use?[J]. Nutr Clin Pract, 2018, 33(1): 133-146.
|
[31] |
HAINES R W, ZOLFAGHARI P, WAN Y, et al. Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma[J]. Intensive Care Med, 2019, 45(12): 1718-1731. doi: 10.1007/s00134-019-05760-5
|
[32] |
VOLBEDA M, HESSELS L, POSMA R A, et al. Time courses of urinary creatinine excretion, measured creatinine clearance and estimated glomerular filtration rate over 30 days of ICU admission[J]. J Crit Care, 2021, 63: 161-166. doi: 10.1016/j.jcrc.2020.09.017
|
[33] |
ZHANG Z H, HO K M, GU H Q, et al. Defining persistent critical illness based on growth trajectories in patients with sepsis[J]. Crit Care, 2020, 24(1): 57.
|
[34] |
FLOWER L, HAINES R W, MCNELLY A, et al. Effect of intermittent or continuous feeding and amino acid concentration on urea-to-creatinine ratio in critical illness[J]. JPEN J Parenter Enteral Nutr, 2022, 46(4): 789-797.
|
[35] |
GUNST J, KASHANI K B, HERMANS G. The urea-creatinine ratio as a novel biomarker of critical illness-associated catabolism[J]. Intensive Care Med, 2019, 45(12): 1813-1815.
|
[36] |
BARRETO E F, POYANT J O, COVILLE H H, et al. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers[J]. Clin Nutr, 2019, 38(3): 1362-1367.
|
[37] |
RAVN B, PROWLE J R, MÁRTENSSON J, et al. Superiority of serum cystatin C over creatinine in prediction of long-term prognosis at discharge from ICU[J]. Crit Care Med, 2017, 45(9): e932-e940.
|
[38] |
AMADO C A, RUIZ DE INFANTE M M. Sarcopenia index: More than an marker of muscle mass[J]. Clin Nutr, 2019, 38(3): 1479.
|
[39] |
BUENDGENS L, YAGMUR E, BRUENSING J, et al. Growth differentiation factor-15 is a predictor of mortality in critically ill patients with sepsis[J]. Dis Markers, 2017, 2017: 5271203. DOI: 10.1155/2017/5271203.
|
[40] |
PATEL S, ALVAREZ-GUAITA A, MELVIN A, et al. GDF15 Provides an endocrine signal of nutritional stress in mice and humans[J]. Cell Metab, 2019, 29(3): 707-718.
|
[41] |
CHUNG H K, RYU D, KIM K S, et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis[J]. J Cell Biol, 2017, 216(1): 149-165.
|
[42] |
XIE Y P, LIU S X, ZHENG H, et al. Utility of plasma GDF-15 for diagnosis and prognosis assessment of ICU-Acquired weakness in mechanically ventilated patients: Prospective observational study[J]. Biomed Res Int, 2020, 2020: 3630568. DOI: 10.1155/2020/3630568.
|
[43] |
BLOCH S A, LEE J Y, SYBURRA T, et al. Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs[J]. Thorax, 2015, 70(3): 219-228.
|